BackgroundMalignant melanoma is an extremely aggressive and metastatic cancer. and highly resistant to conventional therapies. Signal transducer and activator of transcription 3 (STAT3) signaling promotes melanoma development and progression. which has been validated as an effective target in melanoma treatment. https://www.roneverhart.com/Port-Company-Women-s-Tri-Blend-V-Neck-Tee-LPC330V-Port-Company-LPC330V/